ArticleInflammopharmacology2022

Nangibotide attenuates osteoarthritis by inhibiting osteoblast apoptosis and TGF-β activity in subchondral bone.

Yiming Zhong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.